Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands | Total | COMMON STOCK | CAPITAL SURPLUS | ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) | RETAINED EARNINGS |
Balance at beginning of period (in shares) at Dec. 31, 2017 | | 124,261 | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net issuances of restricted stock (in shares) | | 525 | | | |
Repurchases of common stock (in shares) | | (2,341) | | | |
Balance at end of period (in shares) at Jun. 30, 2018 | | 122,445 | | | |
Balance at beginning of period at Dec. 31, 2017 | | $ 124 | $ 1,064,601 | $ 3,507 | $ 37,033 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net issuances of restricted stock | | 1 | (1) | | |
Repurchases of common stock | | (3) | | | (144,482) |
Stock-based compensation expense | | | 21,945 | | |
Foreign currency translation adjustments, net of tax | $ (9,916) | | | (9,916) | |
Net income | 205,482 | | | | 205,482 |
Cash dividends ($.31 per share, $.28 per share, $.62 per share, and $.56 per share) | | | | | (68,793) |
Balance at end of period at Jun. 30, 2018 | | $ 122 | 1,086,545 | (6,409) | 29,240 |
Balance at beginning of period (in shares) at Mar. 31, 2018 | | 123,563 | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net issuances of restricted stock (in shares) | | 12 | | | |
Repurchases of common stock (in shares) | | (1,130) | | | |
Balance at end of period (in shares) at Jun. 30, 2018 | | 122,445 | | | |
Balance at beginning of period at Mar. 31, 2018 | | $ 124 | 1,075,156 | 9,015 | 30,502 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net issuances of restricted stock | | 0 | 0 | | |
Repurchases of common stock | | (2) | | | (75,994) |
Stock-based compensation expense | | | 11,389 | | |
Foreign currency translation adjustments, net of tax | (15,424) | | | (15,424) | |
Net income | 109,315 | | | | 109,315 |
Cash dividends ($.31 per share, $.28 per share, $.62 per share, and $.56 per share) | | | | | (34,583) |
Balance at end of period at Jun. 30, 2018 | | $ 122 | 1,086,545 | (6,409) | 29,240 |
Balance at beginning of period (in shares) at Dec. 31, 2018 | | 119,078 | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net issuances of restricted stock (in shares) | | 552 | | | |
Repurchases of common stock (in shares) | | (2,069) | | | |
Balance at end of period (in shares) at Jun. 30, 2019 | | 117,561 | | | |
Balance at beginning of period at Dec. 31, 2018 | 1,063,198 | $ 119 | 1,079,188 | (16,109) | 0 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net issuances of restricted stock | | 1 | (1) | | |
Repurchases of common stock | | (2) | | | (127,947) |
Stock-based compensation expense | | | 22,914 | | |
Foreign currency translation adjustments, net of tax | 249 | | | 249 | |
Net income | 224,410 | | | | 224,410 |
Cash dividends ($.31 per share, $.28 per share, $.62 per share, and $.56 per share) | | | | | (73,595) |
Balance at end of period at Jun. 30, 2019 | 1,109,227 | $ 118 | 1,102,101 | (15,860) | 22,868 |
Balance at beginning of period (in shares) at Mar. 31, 2019 | | 118,321 | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net issuances of restricted stock (in shares) | | 271 | | | |
Repurchases of common stock (in shares) | | (1,031) | | | |
Balance at end of period (in shares) at Jun. 30, 2019 | | 117,561 | | | |
Balance at beginning of period at Mar. 31, 2019 | | $ 118 | 1,090,432 | (18,006) | 4,485 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net issuances of restricted stock | | 1 | (1) | | |
Repurchases of common stock | | (1) | | | (59,632) |
Stock-based compensation expense | | | 11,670 | | |
Foreign currency translation adjustments, net of tax | | | | 2,146 | |
Net income | 114,612 | | | | 114,612 |
Cash dividends ($.31 per share, $.28 per share, $.62 per share, and $.56 per share) | | | | | (36,597) |
Balance at end of period at Jun. 30, 2019 | $ 1,109,227 | $ 118 | $ 1,102,101 | $ (15,860) | $ 22,868 |